摘要
Objective To investigate the efficacy and adverse effects of first-line immunotherapy combined with chemotherapy in elderly patients with small cell lung cancer(SCLC) in population of real world.Methods A total of 148 elderly SCLC patients (age≥65 years old)underwent pathological diagnosis were retrospectively analyzed from January 2013 to June 2023.
作者
别志欣
BIE Zhixin(Dept Oncol,Beijing Hosp,Natl Gerontol Center,Instit Geriatr Med,CAMS,Beijing 100730)